Makris A - Search Results

1

Hyperhomocysteinemia in women with advanced breast cancer.

Gatt A, Makris A, Cladd H, Burcombe RJ, Smith JM, Cooper P, Thompson D, Makris M. Gatt A, et al. Among authors: makris m, makris a. Int J Lab Hematol. 2007 Dec;29(6):421-5. doi: 10.1111/j.1751-553X.2007.00907.x. Int J Lab Hematol. 2007. PMID: 17988296

2

Pre-treatment haemoglobin levels and the prediction of response to neoadjuvant chemotherapy in breast cancer.

Beresford MJ, Burcombe R, Ah-See ML, Stott D, Makris A. Beresford MJ, et al. Among authors: makris a. Clin Oncol (R Coll Radiol). 2006 Aug;18(6):453-8. doi: 10.1016/j.clon.2006.04.006. Clin Oncol (R Coll Radiol). 2006. PMID: 16909968 Clinical Trial.

3

Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer.

Burcombe RJ, Makris A, Richman PI, Daley FM, Noble S, Pittam M, Wright D, Allen SA, Dove J, Wilson GD. Burcombe RJ, et al. Among authors: makris a. Br J Cancer. 2005 Jan 17;92(1):147-55. doi: 10.1038/sj.bjc.6602256. Br J Cancer. 2005. PMID: 15611798 Free PMC article.

4

Exemestane after non-steroidal aromatase inhibitors for post-menopausal women with advanced breast cancer.

Chin YS, Beresford MJ, Ravichandran D, Makris A. Chin YS, et al. Among authors: makris a. Breast. 2007 Aug;16(4):436-9. doi: 10.1016/j.breast.2007.02.002. Epub 2007 Apr 6. Breast. 2007. PMID: 17418575

5

A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer.

Makris A, Powles TJ, Ashley SE, Chang J, Hickish T, Tidy VA, Nash AG, Ford HT. Makris A, et al. Ann Oncol. 1998 Nov;9(11):1179-84. doi: 10.1023/a:1008400706949. Ann Oncol. 1998. PMID: 9862047 Free article. Clinical Trial.

6

Quantitative changes in cytological molecular markers during primary medical treatment of breast cancer: a pilot study.

Makris A, Powles TJ, Allred DC, Ashley SE, Trott PA, Ormerod MG, Titley JC, Dowsett M. Makris A, et al. Breast Cancer Res Treat. 1999 Jan;53(1):51-9. doi: 10.1023/a:1006179511178. Breast Cancer Res Treat. 1999. PMID: 10206072 Clinical Trial.

7

A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer.

Ford HE, Yap YS, Miles DW, Makris A, Hall M, Miller L, Harries M, Smith IE, Johnston SR. Ford HE, et al. Among authors: makris a. Cancer Chemother Pharmacol. 2006 Dec;58(6):809-15. doi: 10.1007/s00280-006-0222-9. Epub 2006 Mar 10. Cancer Chemother Pharmacol. 2006. PMID: 16528527 Clinical Trial.

8

Studies of the potential utility of Ki67 as a predictive molecular marker of clinical response in primary breast cancer.

Assersohn L, Salter J, Powles TJ, A'hern R, Makris A, Gregory RK, Chang J, Dowsett M. Assersohn L, et al. Among authors: a hern r, makris a. Breast Cancer Res Treat. 2003 Nov;82(2):113-23. doi: 10.1023/B:BREA.0000003968.45511.3f. Breast Cancer Res Treat. 2003. PMID: 14692655 Clinical Trial.

9

Breast-cancer adjuvant therapy with zoledronic acid.

Coleman RE, Marshall H, Cameron D, Dodwell D, Burkinshaw R, Keane M, Gil M, Houston SJ, Grieve RJ, Barrett-Lee PJ, Ritchie D, Pugh J, Gaunt C, Rea U, Peterson J, Davies C, Hiley V, Gregory W, Bell R; AZURE Investigators. Coleman RE, et al. N Engl J Med. 2011 Oct 13;365(15):1396-405. doi: 10.1056/NEJMoa1105195. Epub 2011 Sep 25. N Engl J Med. 2011. PMID: 21995387 Free article. Clinical Trial.

10

Neoadjuvant endocrine therapy in breast cancer.

Beresford MJ, Ravichandran D, Makris A. Beresford MJ, et al. Among authors: makris a. Cancer Treat Rev. 2007 Feb;33(1):48-57. doi: 10.1016/j.ctrv.2006.10.003. Epub 2006 Nov 28. Cancer Treat Rev. 2007. PMID: 17134840 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

424 results

Search Page